ORIC Pharmaceuticals, Inc. 4TZ.F Stock
ORIC Pharmaceuticals, Inc. Price Chart
ORIC Pharmaceuticals, Inc. 4TZ.F Financial and Trading Overview
ORIC Pharmaceuticals, Inc. stock price | 8.25 EUR |
Previous Close | 5.85 EUR |
Open | 5.8 EUR |
Bid | 5.85 EUR x N/A |
Ask | 6 EUR x N/A |
Day's Range | 5.8 - 5.8 EUR |
52 Week Range | 2.38 - 6.4 EUR |
Volume | 300 EUR |
Avg. Volume | 5 EUR |
Market Cap | 266.87M EUR |
Beta (5Y Monthly) | 0.477308 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.66 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 43.43 EUR |
4TZ.F Valuation Measures
Enterprise Value | 76.85M EUR |
Trailing P/E | N/A |
Forward P/E | -2.0138888 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 1.289462 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.871 |
Trading Information
ORIC Pharmaceuticals, Inc. Stock Price History
Beta (5Y Monthly) | 0.477308 |
52-Week Change | 65.22% |
S&P500 52-Week Change | 20.43% |
52 Week High | 6.4 EUR |
52 Week Low | 2.38 EUR |
50-Day Moving Average | 4.81 EUR |
200-Day Moving Average | 4.13 EUR |
4TZ.F Share Statistics
Avg. Volume (3 month) | 5 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 45.09M |
Float | 26.87M |
Short Ratio | N/A |
% Held by Insiders | 14.80% |
% Held by Institutions | 74.00% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -22.22% |
Return on Equity (ttm) | -39.44% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -88219000 EUR |
Net Income Avi to Common (ttm) | -89908000 EUR |
Diluted EPS (ttm) | -2.17 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 189.63M EUR |
Total Cash Per Share (mrq) | 4.21 EUR |
Total Debt (mrq) | 2.68M EUR |
Total Debt/Equity (mrq) | 1.32 EUR |
Current Ratio (mrq) | 12.993 |
Book Value Per Share (mrq) | 4.498 |
Cash Flow Statement
Operating Cash Flow (ttm) | -73053000 EUR |
Levered Free Cash Flow (ttm) | -38988876 EUR |
Profile of ORIC Pharmaceuticals, Inc.
Country | Germany |
State | CA |
City | South San Francisco |
Address | 240 East Grand Avenue |
ZIP | 94080 |
Phone | 650 388 5600 |
Website | https://www.oricpharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 88 |
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. ORIC Pharmaceuticals, Inc. has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Q&A For ORIC Pharmaceuticals, Inc. Stock
What is a current 4TZ.F stock price?
ORIC Pharmaceuticals, Inc. 4TZ.F stock price today per share is 8.25 EUR.
How to purchase ORIC Pharmaceuticals, Inc. stock?
You can buy 4TZ.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ORIC Pharmaceuticals, Inc.?
The stock symbol or ticker of ORIC Pharmaceuticals, Inc. is 4TZ.F.
Which industry does the ORIC Pharmaceuticals, Inc. company belong to?
The ORIC Pharmaceuticals, Inc. industry is Biotechnology.
How many shares does ORIC Pharmaceuticals, Inc. have in circulation?
The max supply of ORIC Pharmaceuticals, Inc. shares is 67.43M.
What is ORIC Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
ORIC Pharmaceuticals, Inc. PE Ratio is now.
What was ORIC Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
ORIC Pharmaceuticals, Inc. EPS is -1.66 EUR over the trailing 12 months.
Which sector does the ORIC Pharmaceuticals, Inc. company belong to?
The ORIC Pharmaceuticals, Inc. sector is Healthcare.